Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001213900-20-015351
Filing Date
2020-06-19
Accepted
2020-06-19 16:05:27
Documents
3

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D ea123226-13dsharma_lantern.htm SC 13D 45067
2 LOCK UP AGREEMENT DATED MAY 20, 2020 ea123226ex99-1_lantern.htm EX-99.1 23849
3 AMENDMENT TO EMPLOYMENT AGREEMENT DATED MAY 18, 2020 WITH PANNA SHARMA ea123226ex99-2_lantern.htm EX-99.2 16469
  Complete submission text file 0001213900-20-015351.txt   86708
Mailing Address 201 ROUTE 17 NORTH RUTHERFORD NJ 07070
Business Address
SHARMA PANNA (Filed by) CIK: 0001157989 (see all company filings)

Type: SC 13D

Mailing Address 1920 MCKINNEY AVENUE 7TH FLOOR DALLAS TX 75201
Business Address 1920 MCKINNEY AVENUE 7TH FLOOR DALLAS TX 75201 972-277-1136
Lantern Pharma Inc. (Subject) CIK: 0001763950 (see all company filings)

EIN.: 463973463 | State of Incorp.: TX | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-91536 | Film No.: 20975659
SIC: 2834 Pharmaceutical Preparations